Patents by Inventor Jiali Li

Jiali Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11956986
    Abstract: A flexible display screen includes: a flexible substrate (1); an OLED device layer (2) formed on the flexible substrate (1); an encapsulation layer(3), disposed on the OLED device layer(2) and encapsulating the OLED device layer (2); and an encapsulation protection layer (4) formed on the encapsulation layer (3). The embodiments of the present disclosure also provide a flexible display device and a manufacturing method of the flexible display screen.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: April 9, 2024
    Assignees: Chengdu BOE Optoelectronics Technology Co., Ltd., BOE Technology Group Co., Ltd.
    Inventors: Yaming Wang, Liqiang Chen, Yanxin Wang, Chuntong Jiang, Jiali Wang, Xu Li, Rui Hou, Le Chang
  • Patent number: 11939307
    Abstract: Disclosed are a benzyl piperazine compound, a preparation method there for and an application thereof in an antivirus. The benzyl piperazine compound has a structure represented by the following general formula(I). It is proven by experiments that the benzyl piperazine compound not only has significant antiviral activity, but also has the advantages of low cytotoxicity, a high selectivity index and soon.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: March 26, 2024
    Assignee: INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
    Inventors: Yanping Li, Zhuorong Li, Zonggen Peng, Xinbei Jiang, Yixuan Wang, Jianrui Li, Jiali Tan
  • Publication number: 20240094174
    Abstract: The present invention relates to the field of product quality analysis, and specifically, a test kit and detection method for testing isothiazolinone in textiles. A pretreatment step of the present invention adopts a unique process, which may fully transfer isothiazolinone to an acetone and water mixed solution, so that a more accurate measurement result can be achieved. The testing method of the present invention dose not add indicators, does not use large-scale analysis instruments, and is accurate in measurement, easy in reaction termination determination, high in accuracy, low in cost, and strong in popularization and application.
    Type: Application
    Filed: September 26, 2022
    Publication date: March 21, 2024
    Inventors: Tangtang Xie, Junfeng Lin, Chengfa Li, Chengyun Wang, Yanhua Li, Jiali Zhang
  • Publication number: 20230210854
    Abstract: Disclosed herein are compounds and combinations of compounds for treating a disease or condition, such as cancer.
    Type: Application
    Filed: May 12, 2021
    Publication date: July 6, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate, Brant Clayton Boren
  • Publication number: 20230087941
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and a WEE1 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: March 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Peter Qinhua Huang, Sayee Gajanan Hegde, Brant Clayton Boren, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230068370
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a WEE1 inhibitor, and a SERD or SERM inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: March 2, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Peter Qinhua Huang, Brant Clayton Boren, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230053946
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and another inhibitor (such as a CDK4/6 inhibitor, a selective aromatase inhibitor, a non-selective aromatase inhibitor, a mTOR inhibitor, a PI3K inhibitor, an ERK or a MEK inhibitor, AKT inhibitor, a BET inhibitor and an Aurora inhibitor), along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Peter Qinhua Huang, Sayee Gajanan Hegde, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230054767
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and a Bcl-2 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Hooman Izadi, Peter Qinhua Huang, Sayee Gajanan Hegde, Joseph Robert Pinchman, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230054854
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a Bcl-2 inhibitor and a WEE1 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 23, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Hooman Izadi, Peter Qinhua Huang, Joseph Robert Pinchman, Brant Clayton Boren, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230042653
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a SERD inhibitor and a WEE1 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: February 9, 2023
    Inventors: Ahmed Abdi Samatar, Jianhui Ma, Jiali Li, Peter Qinhua Huang, Sayee Gajanan Hegde, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20230008362
    Abstract: Disclosed herein are combinations of compounds for treating a disease or condition, such as cancer. A combination of compounds for treating a disease or condition can include a WEE1 inhibitor and a Bcl-2 inhibitor, along with pharmaceutically acceptable salts of any of the foregoing.
    Type: Application
    Filed: December 16, 2020
    Publication date: January 12, 2023
    Inventors: Ahmed Abdi Samatar, Jiali Li, Hooman Izadi, Peter Qinhua Huang, Brant Clayton Boren, Joseph Robert Pinchman, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20220125769
    Abstract: Uses and methods that include an effective amount of Compound (A), or a pharmaceutically acceptable salt thereof, are described herein for treating breast cancer in a subject in need thereof, wherein the breast cancer has at least one point mutation within the Estrogen Receptor 1 (ESR1) that encodes Estrogen receptor alpha (ER?).
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Sayee Gajanan Hegde, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate
  • Patent number: 11278532
    Abstract: Uses and methods that include an effective amount of Compound (A), or a pharmaceutically acceptable salt thereof, are described herein for treating breast cancer in a subject in need thereof, wherein the breast cancer has at least one point mutation within the Estrogen Receptor 1 (ESR1) that encodes Estrogen receptor alpha (ER?).
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: March 22, 2022
    Assignee: Recurium IP Holdings, LLC
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Sayee Gajanan Hegde, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate
  • Publication number: 20210038573
    Abstract: Uses and methods that include an effective amount of Compound (A), or a pharmaceutically acceptable salt thereof, are described herein for treating breast cancer in a subject in need thereof, wherein the breast cancer has at least one point mutation within the Estrogen Receptor 1 (ESR1) that encodes Estrogen receptor alpha (ER?).
    Type: Application
    Filed: August 4, 2020
    Publication date: February 11, 2021
    Inventors: Ahmed Abdi Samatar, Jiali Li, Jianhui Ma, Sayee Gajanan Hegde, Peter Qinhua Huang, Kevin Duane Bunker, Fernando Donate
  • Patent number: 10652532
    Abstract: System and methods of managing reference frame adaptively for video communication under a network are provided. The system adaptively decides the interval between each I frame, the bitrate of the encoded bit steams, and the resolution of the encoded video to achieve quick connection. The system may set the appropriate reference frame(s) for the current frame, manage the reference frame(s) in the DPB to be long/short term reference frame(s) or mark them as unused for reference; mark the current frame to be a long term reference frame, a short term reference frame, unused for reference or skip encoding the current frame; adaptively change the ratio of long term reference frame(s) with respect to the short term reference frame(s) in the DPB; adaptively change the frequency ratio of marking the current frame as long term reference frame and marking the current frame as short term reference frame.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: May 12, 2020
    Assignee: Agora Lab, Inc.
    Inventors: Wei Dai, Zesen Zhuang, Jian Lou, Qianzong Chen, Jiali Li
  • Patent number: 10630994
    Abstract: A decoding method includes: decoding from the video bitstream a prediction status parameter indicative of whether SOP is enabled; if the SOP is enabled, determining a SOP type indicative of a specific operation for predicting a current picture of the video bitstream; and determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom. An encoding method includes: if SOP is enabled, determining SOP data indicative of a specific operation for predicting a current picture of a video sequence; determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom; and encoding the SOP data.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: April 21, 2020
    Assignee: Agora Lab, Inc.
    Inventors: Jiali Li, Jian Lou, Zhenyong Chen, Zhonghou Zheng, Wei Dai, Qianzong Chen
  • Publication number: 20190122546
    Abstract: Embodiments of the disclosure provide methods and systems for adjusting road conditions. The system includes a communication interface configured to receive driving information indicative of vehicle driving records on a road. The road includes first and second direction lanes. The system includes a storage configured to store preset parameters. The system includes a processor configured to divide the road into road segments and determine a first traffic congestion index and a second traffic congestion index for the first direction lane and the second direction lane, respectively, based on the driving information associated with each road segment and the preset parameters. The processor is configured to determine a directional imbalance index for the road based on the first and second traffic congestion indices. The processor is configured to provide an instruction to adjust the first direction lane and/or the second direction lane of the road based on the directional imbalance index.
    Type: Application
    Filed: December 14, 2018
    Publication date: April 25, 2019
    Applicant: BEIJING DIDI INFINITY TECHNOLOGY AND DEVELOPMENT CO., LTD.
    Inventors: Dong LU, Jiali LI
  • Publication number: 20190007687
    Abstract: A decoding method includes: decoding from the video bitstream a prediction status parameter indicative of whether SOP is enabled; if the SOP is enabled, determining a SOP type indicative of a specific operation for predicting a current picture of the video bitstream; and determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom. An encoding method includes: if SOP is enabled, determining SOP data indicative of a specific operation for predicting a current picture of a video sequence; determining a predicted picture by applying the specific operation to at least one of a reference picture for the current picture and the current picture, in which the specific operation includes at least one of rotation and zoom; and encoding the SOP data.
    Type: Application
    Filed: June 28, 2017
    Publication date: January 3, 2019
    Inventors: Jiali Li, Jian Lou, Zhenyong Chen, Zhonghou Zheng, Wei Dai, Qianzong Chen
  • Patent number: 10037670
    Abstract: Systems and methods of a safety belt to be worn by individuals in the course of physical activities such as walking, running, biking, etc. Safety belts of the inventive subject matter include one or more sensors that are used to develop a kinematic status of the individual wearing the safety belt. Kinematic status information can be broadcast out wirelessly, and it can be used to determine whether to generate an alert. Some embodiments of the safety belt can detect the presence of a hazard in the vicinity of an individual wearing the safety belt.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: July 31, 2018
    Inventors: Michelle Jing Lin, Eric Xin Lin, Haitao Lin, Jiali Li
  • Publication number: 20180014010
    Abstract: System and methods of managing reference frame adaptively for video communication under a network are provided. For connection process, based on the network types of all clients and network conditions the system adaptively decides the interval between each I frame, the bitrate of the encoded bit steams, and the resolution of the encoded video to achieve quick connection. Based on the feedback of other clients and network conditions, the system may decide to re-enter the connection stage.
    Type: Application
    Filed: March 2, 2017
    Publication date: January 11, 2018
    Inventors: Wei Dai, Zesen Zhuang, Jian Lou, Qianzong Chen, Jiali Li